Su-Qi Zeng , Jun-Hai Zhen , Yu Pu , Chuan Liu , Jia-Ming Hu , Jun-Jie Chen , Xiao-Li Wang , Wei-Guo Dong
{"title":"1990年至2021年全球、地区和国家老年人(≥60岁)自身免疫性疾病负担:来自2021年全球疾病负担研究的结果","authors":"Su-Qi Zeng , Jun-Hai Zhen , Yu Pu , Chuan Liu , Jia-Ming Hu , Jun-Jie Chen , Xiao-Li Wang , Wei-Guo Dong","doi":"10.1016/j.jnha.2025.100681","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>To analyze and model the global, regional, and national burden of autoimmune diseases (ADs) among older adults (≥60 years) from 1990 to 2021.</div></div><div><h3>Methods</h3><div>Data were extracted from the Global Burden of Disease (GBD) 2021 data for 204 countries and territories. Age-standardized incidence, prevalence, mortality, and disability-adjusted life years (DALY) rates were calculated with 95% uncertainty intervals (UIs). Temporal trends were assessed using estimated annual percentage change (EAPC, with 95% Confidence Intervals [95% CI]). Future trends to 2035 were projected using a log-linear age-period-cohort model.</div></div><div><h3>Results</h3><div>In 2021, the Americas and Europe had the highest burden of ADs in older adults. From 1990 to 2021, age-standardized incidence and prevalence rates increased notably for rheumatoid arthritis (EAPC for incidence rate: 0.75, 0.70−0.79; for prevalence rate: 0.54, 0.50−0.58) and type 1 diabetes (incidence rate: 0.78, 0.70−0.86; prevalence rate:0.84, 0.81-0.88). Psoriasis showed smaller but consistent increases, while inflammatory bowel disease rose only modestly, and multiple sclerosis remained relatively stable. Projections suggest continued increases in age-standardized incidence and prevalence rates for most ADs through 2035.</div></div><div><h3>Conclusions</h3><div>The burden of ADs among older adults is rising globally, with particularly high rates in the Americas and Europe. These findings highlight the urgent need for strategic resource allocation and targeted prevention and management strategies to address ADs in aging populations.</div></div>","PeriodicalId":54778,"journal":{"name":"Journal of Nutrition Health & Aging","volume":"29 11","pages":"Article 100681"},"PeriodicalIF":4.0000,"publicationDate":"2025-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Global, regional, and national burden of autoimmune disease in older adults (≥60 years) from 1990 to 2021: Results from the Global Burden of Disease Study 2021\",\"authors\":\"Su-Qi Zeng , Jun-Hai Zhen , Yu Pu , Chuan Liu , Jia-Ming Hu , Jun-Jie Chen , Xiao-Li Wang , Wei-Guo Dong\",\"doi\":\"10.1016/j.jnha.2025.100681\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><div>To analyze and model the global, regional, and national burden of autoimmune diseases (ADs) among older adults (≥60 years) from 1990 to 2021.</div></div><div><h3>Methods</h3><div>Data were extracted from the Global Burden of Disease (GBD) 2021 data for 204 countries and territories. Age-standardized incidence, prevalence, mortality, and disability-adjusted life years (DALY) rates were calculated with 95% uncertainty intervals (UIs). Temporal trends were assessed using estimated annual percentage change (EAPC, with 95% Confidence Intervals [95% CI]). Future trends to 2035 were projected using a log-linear age-period-cohort model.</div></div><div><h3>Results</h3><div>In 2021, the Americas and Europe had the highest burden of ADs in older adults. From 1990 to 2021, age-standardized incidence and prevalence rates increased notably for rheumatoid arthritis (EAPC for incidence rate: 0.75, 0.70−0.79; for prevalence rate: 0.54, 0.50−0.58) and type 1 diabetes (incidence rate: 0.78, 0.70−0.86; prevalence rate:0.84, 0.81-0.88). Psoriasis showed smaller but consistent increases, while inflammatory bowel disease rose only modestly, and multiple sclerosis remained relatively stable. Projections suggest continued increases in age-standardized incidence and prevalence rates for most ADs through 2035.</div></div><div><h3>Conclusions</h3><div>The burden of ADs among older adults is rising globally, with particularly high rates in the Americas and Europe. These findings highlight the urgent need for strategic resource allocation and targeted prevention and management strategies to address ADs in aging populations.</div></div>\",\"PeriodicalId\":54778,\"journal\":{\"name\":\"Journal of Nutrition Health & Aging\",\"volume\":\"29 11\",\"pages\":\"Article 100681\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2025-09-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Nutrition Health & Aging\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1279770725002064\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GERIATRICS & GERONTOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Nutrition Health & Aging","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1279770725002064","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
Global, regional, and national burden of autoimmune disease in older adults (≥60 years) from 1990 to 2021: Results from the Global Burden of Disease Study 2021
Objectives
To analyze and model the global, regional, and national burden of autoimmune diseases (ADs) among older adults (≥60 years) from 1990 to 2021.
Methods
Data were extracted from the Global Burden of Disease (GBD) 2021 data for 204 countries and territories. Age-standardized incidence, prevalence, mortality, and disability-adjusted life years (DALY) rates were calculated with 95% uncertainty intervals (UIs). Temporal trends were assessed using estimated annual percentage change (EAPC, with 95% Confidence Intervals [95% CI]). Future trends to 2035 were projected using a log-linear age-period-cohort model.
Results
In 2021, the Americas and Europe had the highest burden of ADs in older adults. From 1990 to 2021, age-standardized incidence and prevalence rates increased notably for rheumatoid arthritis (EAPC for incidence rate: 0.75, 0.70−0.79; for prevalence rate: 0.54, 0.50−0.58) and type 1 diabetes (incidence rate: 0.78, 0.70−0.86; prevalence rate:0.84, 0.81-0.88). Psoriasis showed smaller but consistent increases, while inflammatory bowel disease rose only modestly, and multiple sclerosis remained relatively stable. Projections suggest continued increases in age-standardized incidence and prevalence rates for most ADs through 2035.
Conclusions
The burden of ADs among older adults is rising globally, with particularly high rates in the Americas and Europe. These findings highlight the urgent need for strategic resource allocation and targeted prevention and management strategies to address ADs in aging populations.
期刊介绍:
There is increasing scientific and clinical interest in the interactions of nutrition and health as part of the aging process. This interest is due to the important role that nutrition plays throughout the life span. This role affects the growth and development of the body during childhood, affects the risk of acute and chronic diseases, the maintenance of physiological processes and the biological process of aging. A major aim of "The Journal of Nutrition, Health & Aging" is to contribute to the improvement of knowledge regarding the relationships between nutrition and the aging process from birth to old age.